IDEAS home Printed from https://ideas.repec.org/a/srs/jarle0/v2y2011i1p18-47.html
   My bibliography  Save this article

Ex Post Assessment Of Merger Effects The Case Of Pfizer And Pharmacia 2003

Author

Listed:
  • Nina LEHEYDA

    (ZEW Centre for European Economic Research Germany)

  • Patrick BESCHORNER

    (ZEW Centre for European Economic Research Germany)

  • Kai HÜSCHELRATH

    (ZEW Centre for European Economic Research and WHU Otto Beisheim School of Management Germany)

Abstract

The paper studies the effects of the Pfizer and Pharmacia 2003 merger on competition in the Swiss pharmaceutical market and compares the assessment of the Swiss Competition Commission COMCO with the post merger market developments We find that the merger has had a miniscule impact on the Swiss pharmaceutical market This has primarily to do with the fact that the product portfolios of both companies have shown no or only slight overlaps In both cases of potential anticompetitive effects the companies successfully proposed to divest some of their assets in order to prevent a further strengthening of their dominant position The remedies included products in the development phase which were not available on the market at the time of the decision

Suggested Citation

  • Nina LEHEYDA & Patrick BESCHORNER & Kai HÜSCHELRATH, 2011. "Ex Post Assessment Of Merger Effects The Case Of Pfizer And Pharmacia 2003," Journal of Advanced Research in Law and Economics, ASERS Publishing, vol. 2(1), pages 18-47.
    • Handle: RePEc:srs:jarle0:v:2:y:2011:i:1:p:18-47
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Other versions of this item:

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Dubois, Pierre & Majewska, Gosia, 2022. "Mergers and Advertising in the Pharmaceutical Industry," CEPR Discussion Papers 17658, C.E.P.R. Discussion Papers.

    More about this item

    JEL classification:

    • K21 - Law and Economics - - Regulation and Business Law - - - Antitrust Law
    • L42 - Industrial Organization - - Antitrust Issues and Policies - - - Vertical Restraints; Resale Price Maintenance; Quantity Discounts
    • L62 - Industrial Organization - - Industry Studies: Manufacturing - - - Automobiles; Other Transportation Equipment; Related Parts and Equipment

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:srs:jarle0:v:2:y:2011:i:1:p:18-47. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Claudiu Popirlan (email available below). General contact details of provider: http://journals.aserspublishing.eu/jarle .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.